Acumen Pharmaceuticals, Inc. (ABOS)
0.2432
+0.02
(+8.81%)
USD |
NASDAQ |
Nov 09, 11:58
Acumen Pharmaceuticals EPS Diluted (Quarterly) : -0.3508 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.3508 |
| June 30, 2026 | -0.4528 |
| March 31, 2026 | -0.328 |
| December 31, 2025 | -0.415 |
| September 30, 2025 | -0.4367 |
| June 30, 2025 | -0.676 |
| March 31, 2025 | -0.4758 |
| December 31, 2024 | -0.6183 |
| September 30, 2024 | -0.4954 |
| June 30, 2024 | -0.3418 |
| March 31, 2024 | -0.2487 |
| December 31, 2023 | -0.2849 |
| September 30, 2023 | -0.2389 |
| June 30, 2023 | -0.283 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2756 |
| December 31, 2022 | -0.3149 |
| September 30, 2022 | -0.2644 |
| June 30, 2022 | -0.2507 |
| March 31, 2022 | -0.2256 |
| December 31, 2021 | -0.2063 |
| September 30, 2021 | -0.0964 |
| June 30, 2021 | -1.516 |
| March 31, 2021 | -0.6724 |
| December 31, 2020 | -0.0188 |
| September 30, 2020 | -0.062 |
| June 30, 2020 | -0.0503 |
| March 31, 2020 | -0.0509 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.2674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.37M |
| Total Expenses (Quarterly) | 25.37M |
| Enterprise Value | -36.13M |
| Earnings Yield | -635.9% |
| Normalized Earnings Yield | -639.19 |